These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35656280)

  • 1. Comparison of Interferon Gamma Release Assay and Tuberculin Skin Test for Diagnosis of Latent Tuberculosis in Psoriasis Patients Planned for Systemic Therapy.
    Neema S; Sandhu S; Mukherjee S; Vashisht D; Vendhan S; Sinha A; Vasudevan B
    Indian J Dermatol; 2022; 67(1):19-25. PubMed ID: 35656280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis.
    Surve S; Bhor V; Naukariya K; Begum S; Munne K; Tipre P; Sutar N; Jaiswal A; Bhonde G; Chauhan S; Shah I
    J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34904674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
    BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of Tuberculin Skin Test (TST) and T-SPOT.TB Tests for Diagnosis of Latent Tuberculosis Infection (LTBI) in HIV-infected Patients].
    Binay UD; Fincancı M; Fersan E; Karakeçili F
    Mikrobiyol Bul; 2019 Oct; 53(4):388-400. PubMed ID: 31709936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for latent tuberculosis infection in patients with chronic inflammatory arthritis: discrepancies between tuberculin skin test and interferon-γ release assay results.
    Costantino F; de Carvalho Bittencourt M; Rat AC; Loeuille D; Dintinger H; Béné MC; Faure G; Chary-Valckenaere I
    J Rheumatol; 2013 Dec; 40(12):1986-93. PubMed ID: 24085550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of an interferon-gamma release assay and tuberculin skin test in refractory inflammatory disease patients screened for latent tuberculosis prior to the initiation of a first tumor necrosis factor α inhibitor.
    Kwakernaak AJ; Houtman PM; Weel JF; Spoorenberg JP; Jansen TL
    Clin Rheumatol; 2011 Apr; 30(4):505-10. PubMed ID: 20737179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculin test versus interferon gamma release assay in pregnant women with household contacts of tuberculosis patients.
    Chalid MT; Puspawaty D; Tahir AM; Najdah H; Massi MN
    Int J Mycobacteriol; 2022; 11(4):364-370. PubMed ID: 36510919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Study of Optimal Screening for Latent Tuberculosis in Patients with Inflammatory Bowel Disease.
    Al-Taweel T; Strohl M; Pai M; Martel M; Bessissow T; Bitton A; Seidman E; Afif W
    Dig Dis Sci; 2018 Oct; 63(10):2695-2702. PubMed ID: 29968143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concordance between the tuberculin skin test and interferon gamma release assay (IGRA) for diagnosing latent tuberculosis infection in patients with systemic lupus erythematosus and patient characteristics associated with an indeterminate IGRA.
    Cho H; Kim YW; Suh CH; Jung JY; Um YJ; Jung JH; Kim HA
    Lupus; 2016 Oct; 25(12):1341-8. PubMed ID: 26985011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superiority of Interferon Gamma Assay Over Tuberculin Skin Test for Latent Tuberculosis in Inflammatory Bowel Disease Patients in Brazil.
    Amorim RF; Viegas ERC; Carneiro AJV; Esberard BC; Chinem ES; Correa RS; Rodrigues L; Ribeiro-Alves M; Silva KS; de Souza HS; Carvalho ATP
    Dig Dis Sci; 2019 Jul; 64(7):1916-1922. PubMed ID: 30673986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Interferon-Gamma Release Assay versus the Tuberculin Skin Test in the Diagnosis of
    Druszczynska M; Seweryn M; Wawrocki S; Pankowska A; Godkowicz M; Kowalewska-Pietrzak M
    Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-γ release assays: a systematic review and meta-analysis.
    Krutikov M; Faust L; Nikolayevskyy V; Hamada Y; Gupta RK; Cirillo D; Mateelli A; Korobitsyn A; Denkinger CM; Rangaka MX
    Lancet Infect Dis; 2022 Feb; 22(2):250-264. PubMed ID: 34606768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial testing of latent tuberculosis infection in patients with diabetes mellitus using interferon-gamma release assay, tuberculin skin test, and creation tuberculin skin test.
    He Y; Cao X; Guo T; He Y; Du Y; Zhang H; Feng B; Du J; Zhang B; Wang K; Yan J; Wang D; Liu Z; Pan S; Xin H; Gao L
    Front Public Health; 2022; 10():1025550. PubMed ID: 36530654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
    Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
    Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
    Triverio PA; Bridevaux PO; Roux-Lombard P; Niksic L; Rochat T; Martin PY; Saudan P; Janssens JP
    Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculin Skin Test and Quantiferon in BCG Vaccinated, Immunosuppressed Patients with Moderate-to-Severe Inflammatory Bowel Disease.
    Kurti Z; Lovasz BD; Gecse KB; Balint A; Farkas K; Morocza-Szabo A; Gyurcsanyi A; Kristof K; Vegh Z; Gonczi L; Kiss LS; Golovics PA; Lakatos L; Molnar T; Lakatos PL
    J Gastrointestin Liver Dis; 2015 Dec; 24(4):467-72. PubMed ID: 26697573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results.
    Gran G; Aßmus J; Dyrhol-Riise AM
    BMC Public Health; 2013 Apr; 13():353. PubMed ID: 23590619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The feasibility of the interferon gamma release assay and predictors of discordance with the tuberculin skin test for the diagnosis of latent tuberculosis infection in a remote Aboriginal community.
    Alvarez GG; Van Dyk DD; Davies N; Aaron SD; Cameron DW; Desjardins M; Mallick R; Obed N; Baikie M
    PLoS One; 2014; 9(11):e111986. PubMed ID: 25386908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the QuantiFERON®-TB Gold In-Tube Assay and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in an Iranian Referral Hospital.
    Pourakbari B; Yousefi K; Mahmoudi S; Sadeghi RH; Mamishi S
    Infect Disord Drug Targets; 2019; 19(2):141-144. PubMed ID: 29493468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Usefulness of the Tuberculosis Skin Test and the Interferon-gamma Release Assay in the Diagnosis of Latent Tuberculosis Infection in South Korea.
    Jang JY; Park IW; Choi BW; Choi JC
    Osong Public Health Res Perspect; 2014 Dec; 5(Suppl):S18-23. PubMed ID: 25861575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.